Advertisement

Prophylaxis and Treatment of Myocardial Ischaemia by Haemodilution with Fluorocarbon Emulsions

  • N. S. Faithfull
  • M. Fennema
  • W. Erdmann
Part of the Advances in Experimental Medicine and Biology book series (AEMB, volume 215)

Abstract

Fluorocarbons (PFCs), largely inert chemicals with a high solubility for respiratory and other gases, are available in emulsified form in the plasma substitute Fluosol-DA 20% (FDA). This has an oxygen solubility of 0.75 ml per 100 mmHg (Zander and Makowski, 1982; Grote et al., 1985), about two and a half times that in plasma. To take advantage of this difference a high inspired concentration of oxygen is usually administered.

Keywords

Exchange Transfusion Blood Substitute Left Anterior Descend Occlusion Computer Subroutine Oxygen Transport Parameter 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Biro, G.P. (1982). Comparison of acute cardiovascular effects and oxygen-supply following haemodilution with dextran, stroma-free haemoglobin solution and fluorocarbon suspension. Cardiovasc. Res. 16, 194–204.CrossRefGoogle Scholar
  2. Biro G.P. (1983). Fluorocarbon and dextran hemodilution in myocardial ischemia. Canad. J. Surg. 26, 163–168.Google Scholar
  3. Cefalo, R.C., Seeds, J.W., Proctor, H.J. and Baker, V.V. (1984). Maternal and fetal effects of exchange transfusion with a red cell substitute. Am. J. Obstet. Gynecol. 148, 859–867.Google Scholar
  4. Faithfull, N.S. and Cain, S.W. (1987). Critical oxygen delivery during shock following normoxic and hyperoxic haemodilution with fluorocarbons or dextran. This volume.Google Scholar
  5. Faithfull, N.S., Fennema, M. and Erdmann, W. (1986). Haemodilution and myocardial ischaemia - studies with fluorocarbons and dextran in pigs. In: Anaesthesia - Innovation in Management III. Eds Droh, R., Erdmann, W. and Sprintger, R., Springer, Berlin.Google Scholar
  6. Faithfull, N.S., King, C.E. and Cain, S.W. (1986). Critical oxygen delivery during haemorrhagic shock following haemodilution with dextran or fluorocarbons. Brit. J. Anaesth. 58, 817P - 818 P.Google Scholar
  7. Glogar, D.H., Kloner, R.A., Muller, J., DeBoer, L.W.V. and Braunwald, E. (1981). Fluorocarbons reduce myocardial ischemic damage after coronary occlusion. Science, 211, 1439–1441.CrossRefGoogle Scholar
  8. Grote, J., Steuer, K., Muller,R., Sontgerath,C. and Zimmer, K. (1985). 02 and CO2 solubility of the fluorocarbon emulsion Fluosol-DA 20% and 02 and CO2 dissociation curves of blood-Fluosol-DA 20% mixtures. In: Oxygen Transport to Tissue-VII. Eds Kreuzer, F., Cain,S.M., Turek, Z. and Goldstick, T.K., Plenum Press, New York and London, (Adv. Exp. Med. Biol., 191, 453–461 ).Google Scholar
  9. Kelman, G.R. (1966). Digital computer subroutine for conversion of oxygen tension into saturation. J.Appl. Physiol., 21, 1375–1376.Google Scholar
  10. Kodolgie, F.D., Dawson, A.K., Forman, M.B., and Virmani, R. (1985). Effect of perfluorochemical (Fluosol-DA) on infarct morphology in dogs. Virchow Arch. B., 50, 119–134.CrossRefGoogle Scholar
  11. Kohno, S., Baba, T., Miamoto, A. and Niiya, K. (1979). Effect of exchange transfusion with Fluosol-DA 20%, on delivery and consumption of oxygen in rabbits under normal air breathing. In: Proc. IVth Int. Symp. on Perfluorocarbon Blood Substitutes. Ed. Naito, R., Exerpta Medica, Amsterdam, pp. 361–371.Google Scholar
  12. Mitsuno, T., Ohyanagi, H. and Naito, R. (1982). Clinical studies of a perfluorochemical whole blood substitute (Fluosol-DA). Ann. Surg. 195, 60–69.CrossRefGoogle Scholar
  13. Naito, R. and Yokoyama, K. (1978). Fluosol-DA. In: Perfluorochemical Blood Susbstitutes. Technical Information Series No. 5. The Green Cross Corporation, Osaka.Google Scholar
  14. Cardiovascular effects of various colloidal solutions during major surgery. Crit. Care Med. 11, 940–942.Google Scholar
  15. Nishimura, N. and Sugi, T. (1984). Changes of haemodynamics and 02 transport associated with perfluorochemical blood substitute Fluosol-DA. Crit. Care Med. 12, 36–38.CrossRefGoogle Scholar
  16. Nunn, G.R., Dance, G., Peters, J. and Cohn, L.H. (1983). Effect of exchange transfusion on myocardial infarction size in dogs. Am. J.Cardiol. 52, 203–205.CrossRefGoogle Scholar
  17. Oda, Y., Murata, T., and Uehida, Y. (1982). Clinical evaluation of artificial blood substitute (Fluosol-DA 20%) in patients with cerebral ischaemia. Neurol. Surg. 10, 637–644.Google Scholar
  18. Ohyanagi, H., Nakaya, S., Okumura,S. and Saitoh, Y. (1984). Surgical use of Fluosol-DA in Jehovah’s witness patients. Artificial Organs, 8, 10–18.CrossRefGoogle Scholar
  19. Okada, K., Takagi, Y., Kosugi, I. and Kitagaki, T. (1979). Effect of Fluosol-DA tissue oxygenation during normovolemic hemodilution. In: Proc. IVth Int. Symp. on Perfluorochemical Blood Substitutes. Ed. Naito, R., Exerpta Medica, Amsterdam, pp. 391–399.Google Scholar
  20. Peerless, S.J., Nakamura, R., Rodriguez-Salazar, A. and Hunter, I.G. (1985). Modification of cerebral ischemia with Fluosol. Stroke, 16, 38–43.CrossRefGoogle Scholar
  21. Rude, R.E., Glogar, D., Khuri, S.F., Kloner, R.A, Karaffa, S., Muller, J.E., Clark, L.C. and Braunwald, E. (1982). Effect of intravenous fluorocarbons during and without 02 enhancement on acute myocardial ischemic injury assessed by measurement of intramyocardial gas tensions. Am. Heart J. 103, 986–995.CrossRefGoogle Scholar
  22. Schmid-Schoenbein, H., Weiss, J. and Ludwig, H. (1973). A simple method for measuring red cell deformability in models of the microcirculation. Blut, 16, 369–379.CrossRefGoogle Scholar
  23. Smith, A.R., van Alphen, W., Faithfull, N.S. and Fennema, M. (1985). Limb preservation in replantation surgery. J. Plast. Reconstr. Surg. 75, 227–237.Google Scholar
  24. Sutherland, G.R., Farrar, J.K. and Peerless, S.J. (1984). The effect of Fluosol-DA on oxygen availability in focal cerebral ischemia. Stroke, 15, 829–835.CrossRefGoogle Scholar
  25. Tremper, K.K., Friedman, A.E., Levine, E.M., Lapin, R. and Camarillo, D. (1982). The preoperative treatment of severely anemic patients with a perfluorochemical oxygen-transport fluid, Fluosol-DA. N. Eng. J. Med. 307, 277–283.CrossRefGoogle Scholar
  26. Watanabe, M., Hanada, S., Yano, K., Yokoyama, K., Suyama, T. and Naito, R. (1979). Long-term survival of rats severely exchange-transfused with Fluosol-DA. In: Proc. IVth Int. Symp. on Perfluorochemical Blood Substitutes. Ed. Naito, R., Exerpta Medica, Amsterdam, pp. 347–357.Google Scholar
  27. Zander, R. and Makowski, H.V. (1982). Life without hemoglobin? In: Oxygen Carrying Blood Substitutes. Eds Frey, R., Beisbarth, H. and Stossek, K.W., Zuckschwerdt Verlag, Munich, pp. 133–141.Google Scholar

Copyright information

© Plenum Press, New York 1987

Authors and Affiliations

  • N. S. Faithfull
    • 1
  • M. Fennema
    • 1
  • W. Erdmann
    • 1
  1. 1.Department of AnaesthesiaErasmus University RotterdamThe Netherlands

Personalised recommendations